[HTML][HTML] Quantitative susceptibility mapping of brain iron in healthy aging and cognition
DJ Madden, JL Merenstein - NeuroImage, 2023 - Elsevier
Quantitative susceptibility mapping (QSM) is a magnetic resonance imaging (MRI) technique
that can assess the magnetic properties of cerebral iron in vivo. Although brain iron is …
that can assess the magnetic properties of cerebral iron in vivo. Although brain iron is …
Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imaging
A key aim in epidemiological neuroscience is identification of markers to assess brain health
and monitor therapeutic interventions. Quantitative susceptibility mapping (QSM) is an …
and monitor therapeutic interventions. Quantitative susceptibility mapping (QSM) is an …
[HTML][HTML] Depth-wise profiles of iron and myelin in the cortex and white matter using χ-separation: A preliminary study
The in-vivo profiling of iron and myelin across cortical depths and underlying white matter
has important implications for advancing knowledge about their roles in brain development …
has important implications for advancing knowledge about their roles in brain development …
[HTML][HTML] High angular resolution susceptibility imaging and estimation of fiber orientation distribution functions in primate brain
DG Gkotsoulias, R Müller, C Jäger, T Schlumm… - NeuroImage, 2023 - Elsevier
Uncovering brain-tissue microstructure including axonal characteristics is a major
neuroimaging research focus. Within this scope, anisotropic properties of magnetic …
neuroimaging research focus. Within this scope, anisotropic properties of magnetic …
Linking plasma amyloid beta and neurofilament light chain to intracortical myelin content in cognitively normal older adults
M Fernandez-Alvarez, M Atienza, F Zallo… - Frontiers in Aging …, 2022 - frontiersin.org
Evidence suggests that lightly myelinated cortical regions are vulnerable to aging and
Alzheimer's disease (AD). However, it remains unknown whether plasma markers of amyloid …
Alzheimer's disease (AD). However, it remains unknown whether plasma markers of amyloid …